Format

Send to

Choose Destination
See comment in PubMed Commons below
Rev Neurol (Paris). 2011 Nov;167(11):791-801. doi: 10.1016/j.neurol.2011.02.043. Epub 2011 Jun 16.

Genetics for understanding and predicting clinical progression in multiple sclerosis.

Author information

1
Inserm, CNRS, Centre de Recherche de l'Institut Cerveau-Moelle, Hôpital Pitié-Salpêtrière, Université Pierre-et-Marie-Curie Paris-6, UMR 975-7225, 47, Boulevard de l'Hôpital 75013 Paris, France. raphael.de-paz@psl.aphp.fr

Abstract

INTRODUCTION:

Multiple sclerosis (MS) is a dys-immune disease of the central nervous system with highly variable and unpredictable long-term outcome.

STATE OF THE ART:

In the early 1970s association between HLA alleles and MS was established. Very recently, the power of Genome Wide Association Studies (GWAS) enabled the identification of several loci involved in immune functions as genetic risk factors in MS. Recent data suggest that common genetic variations might modulate the clinical phenotype of MS through a regulation of key pathophysiological pathways.

PERSPECTIVES:

Identification of modifier genes might offer an opportunity to explore new relevant therapeutic targets and early prognostic markers. To date, studies of modifier genes in MS are numerous but results are still unclear. This research field may now benefit from large cohorts of patients available for association studies.

CONCLUSION:

In this context, we propose a review of epidemiological and association studies of genetic modifying effect in MS.

PMID:
21683424
DOI:
10.1016/j.neurol.2011.02.043
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Masson (France)
    Loading ...
    Support Center